EST

From WikiMD's WELLNESSPEDIA

EST
EST


Electroconvulsive therapy (ECT), formerly known as electroshock therapy, is a psychiatric treatment in which seizures are electrically induced in patients to provide relief from mental disorders. The procedure is typically administered to patients with severe major depressive disorder, bipolar disorder, and schizophrenia when other treatments have failed. Despite its controversial history, ECT has been found to be effective for some patients and is still used today under strict medical supervision.

The origins of ECT date back to the early 20th century, with the first procedures being carried out in the 1930s. It was initially developed as a treatment for schizophrenia, based on the incorrect hypothesis that epilepsy and schizophrenia could not coexist. Over time, its use was expanded to include a variety of mental health conditions.

The procedure of ECT involves placing electrodes on the patient's scalp and delivering a controlled electric current for a short duration. This current causes a brief seizure, which is believed to produce therapeutic effects. The exact mechanism by which ECT benefits certain mental health conditions is not fully understood, but it is thought to involve changes in brain chemistry and function.

ECT is typically administered in a series of treatments over several weeks. Patients are given a general anesthetic and a muscle relaxant to minimize discomfort and prevent injury during the seizure. The treatment is considered safe, but it can have side effects, including short-term memory loss, confusion, and physical side effects related to the use of anesthesia.

The use of ECT has been a subject of debate and controversy, primarily due to its depiction in media and concerns about its safety and ethical implications. However, it is endorsed by many psychiatric organizations as a valuable treatment option for certain conditions when other treatments have not been effective.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.